Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,969 | 225 | 99.7% |
| Education | $12.51 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $314.30 | 20 | $0 (2024) |
| Eisai Inc. | $251.20 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $248.66 | 11 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $242.23 | 6 | $0 (2024) |
| Amgen Inc. | $221.40 | 14 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $182.33 | 13 | $0 (2024) |
| Celgene Corporation | $160.84 | 9 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $155.29 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $139.10 | 8 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $129.89 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $808.79 | 33 | PROGENICS PHARMACEUTICALS, INC. ($188.11) |
| 2023 | $863.66 | 38 | Myriad Genetic Laboratories, Inc. ($138.00) |
| 2022 | $411.26 | 23 | Merck Sharp & Dohme LLC ($76.59) |
| 2021 | $168.07 | 11 | Novartis Pharmaceuticals Corporation ($60.02) |
| 2020 | $190.95 | 13 | Lilly USA, LLC ($41.96) |
| 2019 | $741.64 | 52 | Novartis Pharmaceuticals Corporation ($81.54) |
| 2018 | $452.47 | 32 | Amgen Inc. ($62.16) |
| 2017 | $345.02 | 24 | Amgen Inc. ($110.73) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/22/2024 | TerSera Therapeutics LLC | Xermelo (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| 09/27/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Oncology | ||||||
| 09/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/11/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | Amneal Pharmaceuticals LLC | AVASTIN (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.16 | General |
| Category: Oncology | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Amneal Pharmaceuticals LLC | AVASTIN (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Oncology | ||||||
| 06/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/31/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Diagnostic Imaging | ||||||
| 05/22/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 04/23/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Oncology | ||||||
| 04/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 04/09/2024 | Amneal Pharmaceuticals LLC | AVASTIN (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: ONCOLOGY | ||||||
| 03/14/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: HEMATOLOGY | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Oncology | ||||||
| 03/12/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,847 | 17,433 | $3.7M | $769,732 |
| 2022 | 33 | 1,876 | 16,239 | $3.5M | $719,040 |
| 2021 | 34 | 1,823 | 13,724 | $3.9M | $804,905 |
| 2020 | 36 | 1,900 | 16,380 | $4.3M | $920,344 |
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 184 | 675 | $992,142 | $174,571 | 17.6% |
| G0340 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | Office | 2023 | 41 | 50 | $382,200 | $93,667 | 24.5% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 62 | 63 | $409,185 | $83,904 | 20.5% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 198 | 700 | $189,336 | $61,542 | 32.5% |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2023 | 11 | 99 | $118,800 | $41,009 | 34.5% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 48 | 48 | $105,421 | $37,008 | 35.1% |
| G0339 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | Office | 2023 | 15 | 15 | $168,900 | $33,950 | 20.1% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 76 | 184 | $173,696 | $31,273 | 18.0% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 105 | 213 | $161,028 | $31,063 | 19.3% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 62 | 70 | $133,762 | $23,902 | 17.9% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 39 | 40 | $32,000 | $23,548 | 73.6% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 57 | 114 | $95,477 | $19,421 | 20.3% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 75 | 305 | $152,195 | $18,872 | 12.4% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 72 | 254 | $92,710 | $12,437 | 13.4% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 65 | 127 | $48,934 | $11,671 | 23.9% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 72 | 74 | $90,502 | $9,525 | 10.5% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 15 | 16 | $31,584 | $7,903 | 25.0% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 37 | 37 | $30,932 | $6,903 | 22.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 40 | 41 | $19,844 | $6,170 | 31.1% |
| 77370 | Special medical radiation therapy consultation | Office | 2023 | 52 | 55 | $32,065 | $5,408 | 16.9% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 16 | 16 | $17,862 | $5,313 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $11,319 | $4,470 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 70 | $9,807 | $4,216 | 43.0% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 52 | 53 | $24,910 | $3,909 | 15.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 55 | 55 | $13,970 | $3,688 | 26.4% |
About Dr. Gregory Rasp, MD
Dr. Gregory Rasp, MD is a Radiation Oncology healthcare provider based in Englewood, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609821842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Rasp, MD has received a total of $3,982 in payments from pharmaceutical and medical device companies, with $808.79 received in 2024. These payments were reported across 226 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($3,969).
As a Medicare-enrolled provider, Rasp has provided services to 7,446 Medicare beneficiaries, totaling 63,776 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location Englewood, OH
- Active Since 05/24/2006
- Last Updated 01/07/2022
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1609821842
Products in Payments
- KEYTRUDA (Biological) $248.66
- PYLARIFY (Drug) $242.23
- Lenvima (Drug) $224.36
- PROLARIS (Device) $138.00
- LIBTAYO (Biological) $131.23
- PLUVICTO (Drug) $106.79
- GILOTRIF (Drug) $103.91
- OPDUALAG (Drug) $98.70
- Neulasta (Biological) $97.82
- Imbruvica (Drug) $81.26
- PROMACTA (Drug) $71.78
- AVASTIN (Drug) $70.18
- ZEPZELCA (Drug) $63.87
- IMBRUVICA (Drug) $63.13
- Kyprolis (Biological) $63.11
- XTANDI (Drug) $61.42
- Nerlynx (Drug) $60.91
- VERZENIO (Drug) $60.67
- Stivarga (Drug) $57.25
- Xofigo (Drug) $55.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Englewood
Guy Savir, Md, MD
Radiation Oncology — Payments: $3,462
Mei Zhang, Md, MD
Radiation Oncology — Payments: $3,274
Dr. Douglas Ditzel, Do, DO
Radiation Oncology — Payments: $2,573
Trevor Bluemel, Md, MD
Radiation Oncology — Payments: $1,445
David Dubin, Md, MD
Radiation Oncology — Payments: $1,198
Jeffrey Gilroy, Md, MD
Radiation Oncology — Payments: $873.55